Dr. Georgianna Long, MD
Claim this profileMelanoma Institute Australia
Studies Cancer
Studies Solid Tumors
1 reported clinical trial
2 drugs studied
More about Georgianna Long, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Georgianna Long, MD has experience with
- NL-201
- Pembrolizumab
Breakdown of trials Georgianna Long, MD has run
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Georgianna Long, MD specialize in?
Georgianna Long, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Georgianna Long, MD currently recruiting for clinical trials?
No, Georgianna Long, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Georgianna Long, MD has studied deeply?
Yes, Georgianna Long, MD has studied treatments such as NL-201, Pembrolizumab.
What is the best way to schedule an appointment with Georgianna Long, MD?
Apply for one of the trials that Georgianna Long, MD is conducting.
What is the office address of Georgianna Long, MD?
The office of Georgianna Long, MD is located at: Melanoma Institute Australia, Sydney, New South Wales 2065 Australia. This is the address for their practice at the Melanoma Institute Australia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.